Company profile for TRACON Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration (“AMD”) and fibrotic diseases. Our lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the VEGF pathway, and is bein...
TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration (“AMD”) and fibrotic diseases. Our lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the VEGF pathway, and is being studied in a pivotal Phase 3 and multiple Phase 2 trials. Our other product candidates are TRC102, a small molecule that is in Phase 2 clinical development for the treatment of mesothelioma and glioblastoma;

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4350 La Jolla Village Dr, San Diego, CA 92121
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/07/30/2921433/10391/en/TRACON-Pharmaceuticals-Announces-it-Will-Wind-Down-Operations.html

GLOBENEWSWIRE
30 Jul 2024

https://www.fiercepharma.com/pharma/china-made-injectable-pd-l1-drug-flunks-pivotal-trial-forcing-us-partner-seek-strategic

FIERCE PHARMA
02 Jul 2024

https://www.globenewswire.com/news-release/2024/07/01/2906758/10391/en/TRACON-Pharmaceuticals-Announces-Termination-of-ENVASARC-Trial-and-Will-Explore-Strategic-Alternatives-Leveraging-its-In-House-Product-Development-Platform.html

GLOBENEWSWIRE
01 Jul 2024

https://www.globenewswire.com/news-release/2024/05/14/2881830/10391/en/TRACON-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
14 May 2024

https://www.globenewswire.com/news-release/2024/05/07/2877173/10391/en/TRACON-to-Report-First-Quarter-2024-Financial-Results-and-Provide-Corporate-Update-on-May-14-2024.html

GLOBENEWSWIRE
06 May 2024

https://www.globenewswire.com/news-release/2024/04/08/2859242/10391/en/TRACON-Pharmaceuticals-Announces-Reverse-Stock-Split.html

GLOBENEWSWIRE
08 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty